The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), on behalf of the National Institutes of Health (NIH), invites all stakeholders to submit nominations for drug, vaccine, and dietary supplement research needs to be considered in the development of a Priority List of Drug, Vaccine, and Dietary Supplement Research Needs for Pregnant, Postpartum, and Lactating Persons.
The 21st Century Cares Act established the Task Force for Research Specific to Pregnant and Lactating Women (PRGLAC) to provide advice and guidance to the HHS Secretary on activities related to identifying and addressing gaps in knowledge and research on safe and effective therapies for pregnant and lactating persons, including the development of such therapies and the collaboration on and coordination of such activities.
Because so few studies have been conducted, some prioritization is necessary to determine which drugs, vaccines, and dietary supplements should be studied first.
Nominations for the Priority List of Drug, Vaccine, and Dietary Supplement Research Needs for Pregnant, Postpartum, and Lactating Persons are solicited in furtherance of the recommendations outlined in the 2018 PRGLAC Report and 2020 PRGLAC Implementation Plan.
View the Request for Information (RFI) at the following link: https://grants.nih.gov/grants/guide/notice-files/NOT-HD-23-013.html
Submit your nominations at the following link: https://www.surveymonkey.com/r/PRGLAC23
You may submit the form multiple times if you would like to submit more than one nomination. Nominations will be accepted through September 29, 2023.
For more information about PRGLAC, please visit https://www.nichd.nih.gov/about/advisory/PRGLAC.